АНАЛІЗ НОМЕНКЛАТУРИ СЕДАТИВНИХ ТА СНОДІЙНИХ ПРЕПАРАТІВ В УКРАЇНІ
DOI:
https://doi.org/10.11603/2312-0967.2015.3.4932Abstract
THE ANALYSIS OF NOMENCLATURE OF SEDATIVE AND somnolent DRUGS IN UKRAINE
Е.V. Savelyeva, I.N. Vladymyrova
National University of Pharmacy, Kharkiv
Summary: the assortment of the modern sedative and somnolent drugs presented at the pharmaceutical market of Ukraine has been analyzed. It has been established that pharmaceutical manufactories of Ukraine occupy 76,70 % of market. Synthetic drugs occupy 22,33 % of market, plants drugs – 77,67 %. Monodrugs are presented by drugs of Valeriana officinalis, Paeonia anomala and Leonurus cardiaca. Results in relation to correlation of producing forms prove, that medicinal forms as pills and tincture occupy the largest segments. It established the monotony of species of medicinal plants, which is part of sedative and somnolent drugs.Key words: sedative drugs, somnolent drugs, drugs nomenclature, phytotherapeutic drugs.
Introduction. Nervous system diseases can result from a variety of reasons, including stress, violations of the day, inactive lifestyle, prolonged tension etc. Most of the adult population of the planet is experiencing problems with the nervous system. The most common way of life associated with a variety of stressors, and being the main reason of the most nervous disorders. Diseases of the nervous system can take many forms – from headaches to epileptic seizures. But completely eliminate stress from your life virtually impossible. The maximum that we can do is to reduce their number to a minimum. Drugs having a widespread action on neurotransmitters system with complex effect on the etiological factors, pathogenic link and symptomatic manifestations of the disease are used for this purpose.
Research methods. This research was conducted by conventional statistical and marketing study of electronic and paper sources. The object of the work was information on sedatives and sleeping pills registered in Ukraine.
Results and discussion. In order to study herbal sedatives and sleeping pills, registered in Ukraine, and analysis of medicinal plants species that are part of these medications, the nomenclature of this group of drugs on regional market was examined. According to the ATC classification system, drugs of this segment are represented by following groups: combined drugs of barbiturates; medications that close to benzodiazepines; Melatonin receptor agonists, bromides and dexmedetomidine drugs as well as a group of other sedatives and sleeping pills. The latter group includes drugs based on Valeriana officinalis, Paeonia anomala and Leonurus cardiaca and combined herbal preparations.
Analyzing the contribution of each country of origin provided on the domestic pharmaceutical market, it was found that sedatives and hypnotics of Ukrainian pharmaceutical companies occupies 76,70%; Germany - 6,80%; Poland – 2,91%; US, Czech Republic, Slovenia and France – 1,94%; Latvia, Turkey, Canada, Hungary, Finland, Belarus - 0,97%.
Analyzing the state of the Ukrainian pharmaceutical market of sedatives and sleeping pills origin was found that synthetic drugs occupy 22,33% of the market and herbal products – 77,67%.
Herbal medicines are divided into two groups: mono-drugs and combination herbal product. Mono-drugs are presented by Valeriana, Paeonia and Leonurus drugs. It should be noted the uniformity of dosage forms for this group.
When using phytotherapeutic remedies for effective therapy it is important take into account the mechanism of their action and specifics of pharmacological action on human’ body.
Conclusions. Analyzing the types of medicinal plants that are present in sedatives and hypnotics, their monotony was established. The perspective in this area can be research of other types of medicinal plants having neurotransmitter action as a source for creating phytotherapeutic agents.
Downloads
Published
How to Cite
Issue
Section
License
The authors who publish their materials in this journal agree with the following terms:
- Authors reserve the right to authorship of their work and assign to the journal the right to first publish this work under the terms of the Creative Commons Attribution License, which allows other persons to freely distribute the published work with a mandatory reference to the authors of original work and the first publication of work in this journal
.
- Authors have the right to make independent extra-exclusive work agreements in the form they are published by this journal (for example, posting work in an electronic repository of an institution or publishing as part of a monograph), provided that the link to the first publication of the work in this journal is maintained.
Journal policy allows and encourages publication of manuscripts on the Internet (for example, in institutions repositories or on personal websites), both before the publication of this manuscript and during its editorial review, as it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the citation of the published work (see The Effect of Open Access).